Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$189.27 - $231.83 $113,562 - $139,098
600 Added 37.5%
2,200 $446,000
Q3 2022

Nov 14, 2022

BUY
$189.27 - $231.83 $113,562 - $139,098
600 Added 37.5%
2,200 $446,000
Q2 2022

Aug 15, 2022

BUY
$194.09 - $276.37 $19,409 - $27,637
100 Added 6.67%
1,600 $318,000
Q1 2022

May 16, 2022

BUY
$245.33 - $277.77 $171,731 - $194,439
700 Added 87.5%
1,500 $401,000
Q4 2021

Feb 14, 2022

SELL
$236.63 - $276.44 $3.41 Million - $3.98 Million
-14,400 Reduced 94.74%
800 $214,000
Q3 2021

Nov 15, 2021

BUY
$248.9 - $280.09 $871,150 - $980,314
3,500 Added 29.91%
15,200 $4.01 Million
Q2 2021

Aug 16, 2021

BUY
$242.95 - $267.0 $1.65 Million - $1.82 Million
6,800 Added 138.78%
11,700 $3.04 Million
Q4 2020

Feb 16, 2021

BUY
$202.01 - $245.04 $989,849 - $1.2 Million
4,900 New
4,900 $1.2 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.